Sp662
PANEL DISCUSSION
Date
May 19, 2024
Explore related products in the following collection:
Presenters
Tracks
Related Products
ASSOCIATION OF ULTRA-PROCESSED FOODS WITH GUT MICROBIOME, GUT PERMEABILITY, AND FECAL CALPROTECTIN IN HEALTHY FIRST DEGREE RELATIVE OF CD PATIENTS
The incidence of inflammatory bowel disease (IBD) is increasing globally. Epidemiological studies suggest an association between consumption of ultra-processed foods (UPFs) and IBD risk…
IMPACT OF ARTIFICIAL INTELLIGENCE SYSTEMS FOR UPPER GASTROINTESTINAL BLEEDING ON CLINICIAN TRUST AND LEARNING USING LARGE LANGUAGE MODELS: A RANDOMIZED PILOT SIMULATION STUDY
Artificial intelligence (AI)-based risk stratification systems in upper gastrointestinal bleeding (UGIB) outperform existing risk scores, but successful implementation of such systems into practice requires acceptance and trust of the technology by clinicians…
PROTON PUMP INHIBITOR THERAPY DOES NOT INCREASE THE RISK OF VASCULAR LESIONS ON MRI OR COGNITIVE DECLINE: RESULTS OF A DOUBLE BLIND RANDOMIZED, PLACEBO CONTROLLED COMPASS MIND SUB-STUDY
INTRODUCTION: Proton pump inhibitors (PPIs) have been associated with an increased risk of cerebrovascular events, cognitive decline, and dementia in observational studies. These associations may be due to residual confounding…
DEVELOPMENT AND VALIDATION OF AN INTEGRATED RISK SCORE FOR PREDICTING FUTURE RISK OF CROHN'S DISEASE UP TO 7 YEARS BEFORE DIAGNOSIS IN HEALTHY FIRST-DEGREE RELATIVES: THE CCC-GEM PROJECT, A MULTICENTRE PROSPECTIVE COHORT STUDY
Although the cause of Crohn’s disease (CD) is unknown, recent studies have identified a number of biomarkers associated with the risk of developing CD in healthy at-risk individuals…
